Todd Longsworth joined Novocure in April 2012 and serves as General Counsel. Mr. Longsworth was previously Chief of Mergers & Acquisitions, Securities and Corporate Governance Counsel for Cephalon, Inc. Prior to joining Cephalon, he was an associate at WilmerHale LLP in Boston. Mr. Longsworth earned his B.A. from Duke University and his J.D. from the University of Pennsylvania.
novocuretrial.com The science of Tumor Treating Fields extends beyond glioblastoma and mesothelioma. Novocure has ongoing or completed clinical trials investigating our therapy in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer and ovarian cancer.